Supreme Court Series: Teva Pharaceuticals USA v. Sandoz Post Argument Discussion

In PIJIP’s ongoing Supreme Court Series, a panel of counsel for amici and parties discussed the case on the afternoon following oral argument before the Court. 

Issue: Whether a district court’s factual finding in support of its construction of a patent claim term may be reviewed de novo, as the Federal Circuit requires (and as the panel explicitly did in this case), or only for clear error, as Federal Rule of Civil Procedure 52(a) requires. 

For the webcast please go to: